2031년까지 글로벌 및 싱가포르 암 치료제 시장 전망

Global & Singapore Cancer Therapeutics Market to 2031

상품코드Saudi Arabia Cancer Therapeutics Market.pdf
발행기관Business Market Insights
발행일2025.05.26
페이지 수100 Pages
포맷PDF
커버리지Country

₩3,600,000 – ₩6,600,000

보고서 요약(국문)

싱가포르의 암 치료제 시장은 정부의 강력한 지원과 지속적인 연구 및 혁신에 힘입어 성장하고 있습니다. 500만 명이 넘는 인구를 가진 싱가포르는 암 발병률이 증가하면서 주요 사망 원인 중 하나가 되었습니다. 전 세계 암 치료가 발전함에 따라 싱가포르는 종양학 신약 개발의 중심지로 부상하여 국내외 제약 회사들이 연구를 수행하고 새로운 치료법을 개발하도록 유치하고 있습니다. 이 시장은 표적 치료, 면역 치료, 정밀 의학에 대한 수요 증가로 특징지어지며, 이러한 치료법들은 더욱 개인화되고 효과적인 치료 옵션을 제공함으로써 암 치료에 혁명을 일으켰습니다.

싱가포르 암 컨소시엄(SCC)과 국립연구재단(NRF)과 같은 정부 주도 프로그램은 종양학 연구를 촉진하고 임상 시험을 지원하는 데 중요한 역할을 합니다. 공공 의료 기관, 학계, 산업계 이해관계자들이 참여하는 SCC는 싱가포르 내 암 생물학 연구, 신약 개발 및 임상 연구를 지원합니다. 이 컨소시엄을 통해 싱가포르는 분자 수준의 암 프로파일링과 표적 치료제 개발에 중점을 둔 임상 시험을 수행하며 정밀 의학 분야의 선두 주자로 자리매김했습니다. 이러한 노력들은 개인 맞춤형 치료 접근법에 상당한 진전을 가져왔으며, 개별 유전적 특성에 맞춰 치료법을 조정함으로써 환자의 치료 결과를 향상시켰습니다.

보고서 요약(영어 원문)

The cancer therapeutics market in Singapore is propelled by strong government backing and continuous advancements in research and innovation. With a population exceeding 5 million, Singapore is experiencing a rise in cancer cases, making it one of the top causes of mortality in the country. As global cancer care evolves, Singapore has emerged as a prominent center for oncology drug development, attracting both domestic and international pharmaceutical companies to conduct research and launch new treatments. The market is marked by increasing demand for targeted therapies, immunotherapies, and precision medicine, which have revolutionized cancer treatment by providing more personalized and effective options.

Government-led programs such as the Singapore Cancer Consortium (SCC) and the National Research Foundation (NRF) play crucial roles in promoting oncology research and facilitating clinical trials. The SCC, a partnership among public healthcare institutions, academic bodies, and industry stakeholders, supports cancer biology research, drug discovery, and clinical studies within the country. Through this consortium, Singapore has positioned itself as a leader in precision medicine by conducting clinical trials focused on molecular cancer profiling and the creation of targeted therapies. These initiatives have driven significant progress in personalized treatment approaches, enhancing patient outcomes by tailoring therapies to individual genetic characteristics.

상세 목차

TABLE OF CONTENTS

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation:

4. Singapore Cancer Therapeutics Market Landscape

4.1 Overview

4.2 Ecosystem Analysis

4.2.1 List of Vendors in the Value Chain

5. Cancer Therapeutics Market Key Market Dynamics

5.1 Cancer Therapeutics Market – Key Market Dynamics

5.2 Market Drivers

5.3 Market Restraints

5.4 Market Opportunities

5.5 Future Trends

5.6 Impact of Drivers and Restraints

6. Singapore Cancer Therapeutics Market – Analysis

6.1 Singapore Cancer Therapeutics Market Revenue (US$ Million), 2021–2031

6.2 Singapore Cancer Therapeutics Market Revenue and Forecast Analysis

7. Singapore Cancer Therapeutics Market Analysis – by Therapy Types

7.1 Singapore Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Therapy Types

8. Singapore Cancer Therapeutics Market Analysis – by Indications

8.1 Singapore Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Indications

9. Singapore Cancer Therapeutics Market Analysis – by Distribution Channel

9.1 Singapore Cancer Therapeutics Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Distribution Channel

10. Competitive Landscape

10.1 Heat Map Analysis by Key Players

10.1 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.2 Partnerships and Collaborations

11.2 Other Developments

12. Company Profiles

12.1 Bristol-Myers Squibb Co

12.1. 1 Key Facts

12.1. 2 Business Description

12.1. 3 Products and Services

12.1. 4 Financial Overview

12.1. 5 SWOT Analysis

12.1. 6 Key Developments

12.2 AbbVie Inc

12.2. 1 Key Facts

12.2. 2 Business Description

12.2. 3 Products and Services

12.2. 4 Financial Overview

12.2. 5 SWOT Analysis

12.2. 6 Key Developments

12.3 Johnson & Johnson

12.3. 1 Key Facts

12.3. 2 Business Description

12.3. 3 Products and Services

12.3. 4 Financial Overview

12.3. 5 SWOT Analysis

12.3. 6 Key Developments

12.4 F. Hoffmann-La Roche Ltd

12.4. 1 Key Facts

12.4. 2 Business Description

12.4. 3 Products and Services

12.4. 4 Financial Overview

12.4. 5 SWOT Analysis

12.4. 6 Key Developments

12.5 Pfizer Inc

12.5. 1 Key Facts

12.5. 2 Business Description

12.5. 3 Products and Services

12.5. 4 Financial Overview

12.5. 5 SWOT Analysis

12.5. 6 Key Developments

12.6 AstraZeneca Plc

12.6. 1 Key Facts

12.6. 2 Business Description

12.6. 3 Products and Services

12.6. 4 Financial Overview

12.6. 5 SWOT Analysis

12.6. 6 Key Developments

12.7 Merck KGaA

12.7. 1 Key Facts

12.7. 2 Business Description

12.7. 3 Products and Services

12.7. 4 Financial Overview

12.7. 5 SWOT Analysis

12.7. 6 Key Developments

12.8 Novartis AG

12.8. 1 Key Facts

12.8. 2 Business Description

12.8. 3 Products and Services

12.8. 4 Financial Overview

12.8. 5 SWOT Analysis

12.8. 6 Key Developments

12.9 Astellas Pharma Inc

12.9. 1 Key Facts

12.9. 2 Business Description

12.9. 3 Products and Services

12.9. 4 Financial Overview

12.9. 5 SWOT Analysis

12.9. 6 Key Developments

12.10 Eli Lilly and Co

12.10. 1 Key Facts

12.10. 2 Business Description

12.10. 3 Products and Services

12.10. 4 Financial Overview

12.10. 5 SWOT Analysis

12.10. 6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

언급된 주요 기업들

TABLE OF COMPANIES

1. Bristol-Myers Squibb Co

2. AbbVie Inc

3. Johnson & Johnson

4. F. Hoffmann-La Roche Ltd

5. Pfizer Inc

6. AstraZeneca Plc

7. Merck KGaA

8. Novartis AG

9. Astellas Pharma Inc

10. Eli Lilly and Co

표 목록 (Tables)

TABLE OF TABLES

Table 1. Singapore Cancer Therapeutics Market Segmentation

Table 2. List of Vendors

Table 3. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million)

Table 4. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million)

Table 5. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Therapy Types

Table 6. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Therapy Types

Table 7. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Indications

Table 8. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Indications

Table 9. Singapore Cancer Therapeutics Market – Revenue, 2021–2024 (US$ Million) – by Distribution Channel

Table 10. Singapore Cancer Therapeutics Market – Revenue Forecast, 2025–2031 (US$ Million) – by Distribution Channel

Table 11. List of Abbreviations

그림 목록 (Figures)

TABLE OF FIGURES

Figure 1. Impact Analysis of Drivers and Restraints

Figure 2. Singapore Cancer Therapeutics Market Revenue, (US$ Million), 2021–2031

Figure 3. Heat Map Analysis by Key Players

Figure 4. Company Positioning and Concentration